Foresite Capital Management IV as of Dec. 31, 2022
Portfolio Holdings for Foresite Capital Management IV
Foresite Capital Management IV holds 8 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kinnate Biopharma | 25.2 | $59M | 9.7M | 6.10 | |
| Aclaris Therapeutics (ACRS) | 18.9 | $44M | 2.8M | 15.75 | |
| Pharvaris N V (PHVS) | 15.6 | $37M | 3.2M | 11.25 | |
| Lyell Immunopharma (LYEL) | 14.8 | $35M | 10M | 3.47 | |
| Kura Oncology (KURA) | 9.8 | $23M | 1.8M | 12.41 | |
| Syndax Pharmaceuticals (SNDX) | 9.5 | $22M | 875k | 25.45 | |
| Cymabay Therapeutics | 4.8 | $11M | 1.8M | 6.27 | |
| Quantum-Si Incorporated Com Cl A (QSI) | 1.4 | $3.2M | 1.8M | 1.83 |
